These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1489185)
1. Penetration of zidovudine and 3'-fluoro-3'-deoxythymidine into the brain, muscle tissue, and veins in cynomolgus monkeys: relation to antiviral action. Ljungdahl-Ståhle E; Guzenda E; Böttiger D; Wahren B; Oberg B; Ståhle L Antimicrob Agents Chemother; 1992 Nov; 36(11):2418-22. PubMed ID: 1489185 [TBL] [Abstract][Full Text] [Related]
2. Antiviral effects of 3'-fluorothymidine and 3'-azidothymidine in cynomolgus monkeys infected with simian immunodeficiency virus. Lundgren B; Böttiger D; Ljungdahl-Ståhle E; Norrby E; Ståhle L; Wahren B; Oberg B J Acquir Immune Defic Syndr (1988); 1991; 4(5):489-98. PubMed ID: 2016686 [TBL] [Abstract][Full Text] [Related]
3. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine. Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and extracellular distribution to blood, brain, and muscle of alovudine (3'-fluorothymidine) and zidovudine in the rat studied by microdialysis. Ståhle L; Guzenda E; Ljungdahl-Ståhle E J Acquir Immune Defic Syndr (1988); 1993 May; 6(5):435-9. PubMed ID: 8483107 [TBL] [Abstract][Full Text] [Related]
5. Antiviral effects of 6-chloro-2',3'-dideoxyguanosine in rhesus monkeys acutely infected with simian immunodeficiency virus. Fujii Y; Mukai R; Akari H; Machida M; Mori K; Takasaka M; Kojima E; Murakami K; Yoshikawa Y Antivir Chem Chemother; 1998 Jan; 9(1):85-92. PubMed ID: 9875380 [TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine. Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406 [TBL] [Abstract][Full Text] [Related]
7. Long-term tolerance and efficacy of 3'-azidothymidine and 3'-fluorothymidine treatment of asymptomatic monkeys infected with simian immunodeficiency virus. Böttiger D; Ståhle L; Li SL; Oberg B Antimicrob Agents Chemother; 1992 Aug; 36(8):1770-2. PubMed ID: 1416863 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of synergy between carbovir and 3'-azido-2',3'-deoxythymidine for inhibition of human immunodeficiency virus type 1. Smith MS; Kessler JA; Rankin CD; Pagano JS; Kurtzberg J; Carter SG Antimicrob Agents Chemother; 1993 Jan; 37(1):144-7. PubMed ID: 8431013 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antiviral (HIV-1, HBV) activities of 5-halo-6-methoxy(or azido)-5,6-dihydro-3'-fluoro-3'-deoxythymidine diastereomers. Potential prodrugs to 3'-fluoro-3'-deoxythymidine. Kumar R; Wang L; Wiebe LI; Knaus EE J Med Chem; 1994 Oct; 37(21):3554-60. PubMed ID: 7932583 [TBL] [Abstract][Full Text] [Related]
10. 5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile. Daluge SM; Purifoy DJ; Savina PM; St Clair MH; Parry NR; Dev IK; Novak P; Ayers KM; Reardon JE; Roberts GB Antimicrob Agents Chemother; 1994 Jul; 38(7):1590-603. PubMed ID: 7526782 [TBL] [Abstract][Full Text] [Related]
11. Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro. Carter SG; Kessler JA; Rankin CD Antimicrob Agents Chemother; 1990 Jun; 34(6):1297-300. PubMed ID: 2393292 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys. Schinazi RF; Boudinot FD; Doshi KJ; McClure HM Antimicrob Agents Chemother; 1990 Jun; 34(6):1214-9. PubMed ID: 2168144 [TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone. Spector SA; Ripley D; Hsia K Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440 [TBL] [Abstract][Full Text] [Related]
14. Plasma drug levels compared with DNA incorporation of 3'-azido-3'-deoxythymidine (AZT) in adult cynomolgus (Macaca fascicularis) monkeys. Olivero OA; Reddy MK; Pietras SM; Poirier MC Exp Biol Med (Maywood); 2001 May; 226(5):446-9. PubMed ID: 11393173 [TBL] [Abstract][Full Text] [Related]
15. Zidovudine concentration in brain extracellular fluid measured by microdialysis: steady-state and transient results in rhesus monkey. Fox E; Bungay PM; Bacher J; McCully CL; Dedrick RL; Balis FM J Pharmacol Exp Ther; 2002 Jun; 301(3):1003-11. PubMed ID: 12023531 [TBL] [Abstract][Full Text] [Related]
16. Enhanced in vitro inhibition of HIV-1 replication by 3'-fluoro-3'-deoxythymidine compared to several other nucleoside analogs. Hartmann H; Vogt MW; Durno AG; Hirsch MS; Hunsmann G; Eckstein F AIDS Res Hum Retroviruses; 1988 Dec; 4(6):457-66. PubMed ID: 3219235 [TBL] [Abstract][Full Text] [Related]
17. Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro. Tsai CC; Follis KE; Benveniste RE AIDS Res Hum Retroviruses; 1988 Oct; 4(5):359-68. PubMed ID: 2461724 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1. Koshida R; Cox S; Harmenberg J; Gilljam G; Wahren B Antimicrob Agents Chemother; 1989 Dec; 33(12):2083-8. PubMed ID: 2533474 [TBL] [Abstract][Full Text] [Related]